Ironwood Pharmaceuticals Inc. Receives $50,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d006ffba-4ecd-4ff1-a176-a4fb19bcd930&Preview=1 -
Date
10/2/2008 -
Company Name
Ironwood Pharmaceuticals Inc. -
Mailing Address
320 Bent Street Cambridge, MA 02141 -
Company Description
We are committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit. Our team is forging a process for creating and developing novel drug candidates that integrates the most successful drugmaking practices of the past and the best of today’s cutting-edge technologies. Our efficient discovery and development processes, focused on important human needs, are generating a robust pipeline. -
Website
http://www.ironwoodpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$50,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This infusion of equity capital will enable us to execute on our comprehensive development plans for linaclotide, which has the potential to benefit millions of patients; advance our pipeline of therapeutic candidates; and grow our sales and marketing team to commercialize our products. -
M&A Terms
-
Venture Investor
Morgan Stanley Venture Partners -
Venture Investor
Ridgeback Capital -
Venture Investor
Fidelity BioSciences -
Venture Investor
Paperboy Ventures -
Venture Investor
Polaris Venture Partners -
Venture Investor
Venrock
